The 1 analysts offering 12-month price forecasts for Purple Biotech Ltd have a median target of 25.00, with a high estimate of 25.00 and a low estimate of 25.00. The median estimate represents a +765.05% increase from the last price of 2.89.
The current consensus among 1 polled investment analysts is to Buy stock in Purple Biotech Ltd. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.90
Reporting Date TBD
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.